T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab.
Bughani U, Saha A, Kuriakose A, Nair R, Sadashivarao RB, Venkataraman R, Patel S, Deshchougule AT, S SK, Montero E, Pai HV, Palanivelu DV, Melarkode R, Nair P.
Bughani U, et al. Among authors: kuriakose a.
PLoS One. 2017 Jul 3;12(7):e0180088. doi: 10.1371/journal.pone.0180088. eCollection 2017.
PLoS One. 2017.
PMID: 28672038
Free PMC article.